AVAH

Aveanna Healthcare Holdings Inc. Common Stock

AVAH
Closed
$9.85
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. The company is headquartered in Atlanta, Georgia and currently employs 3,500 full-time employees. The company went IPO on 2021-04-29. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The company also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
Country

US

CEO

Mr. Jeffrey Shaner

IPO date

2021

Employees

3,500

ISIN

US05356F1057

Key stats

Open

$9.56

Volume

2.41M

Market cap

$2.09B

Prev. close

$9.82

Impl / hst vl

-

Open interest

$0.00

$9.31

Day’s Range

$9.88

$5.93

52W Range

$9.80

Valuation

44
Valuation score
Fairly Valued
P/E
7.99
P/S
0.83
P/B
8.67
Current ratio
1.47
Debt / Equity
5.29
ROE
157.75%
Gross margin
31.71%
Income growth
-76.70%
FCF growth
-100.44

Analysts estimates

Consensus rating
Buy

The average rating from top 7 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$10.48
The top 12 analysts forecasts that 12-month price may increase by 6.43%, with a low of $8.08 and a high of $13.65
$8.08
Low
$10.48
Avg
$13.65
High
Current price

Earnings

Q2 ‘26 revenue
$647.92M
Q2 ‘26 net income
$41.65M
Revenue
Net income
Previous EPS
$0.18
Estimate EPS
$0.17
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply